Literature DB >> 6901591

Antimicrobial susceptibility of Aeromonas hydrophila.

T L Overman.   

Abstract

Minimal inhibitory concentration determinations and disk diffusion and Autobac 1 susceptibility tests were performed on 22 strains of Aeromonas hydrophila. Eleven of the strains had discrepancies between Autobac and disk diffusion or minimal inhibitory concentration results. These discrepancies occurred with the beta-lactam antibiotics, primarily carbenicillin and cephalothin. It is recommended that any strain of A. hydrophila found to be susceptible to any of the beta-lactam antibiotics by using Autobac 1 should be retested by a disk diffusion or minimal inhibitory concentration method.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6901591      PMCID: PMC283840          DOI: 10.1128/AAC.17.4.612

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  5 in total

1.  Laboratory evaluation of a rapid, automatic susceptibility testing system: report of a collaborative study.

Authors:  C Thornsberry; T L Gavan; J C Sherris; A Balows; J M Matsen; L D Sabath; F Schoenknecht; L D Thrupp; J A Washington
Journal:  Antimicrob Agents Chemother       Date:  1975-04       Impact factor: 5.191

2.  The genus aeromonas in human bacteriology; report of 30 cases and review of the literature.

Authors:  A Von Graevenitz; A H Mensch
Journal:  N Engl J Med       Date:  1968-02-01       Impact factor: 91.245

3.  Evaluation of the micro-media system for quantitative antimicrobial drug susceptibility testing: a collaborative study.

Authors:  A L Barry; R N Jones; T L Gavan
Journal:  Antimicrob Agents Chemother       Date:  1978-01       Impact factor: 5.191

4.  Laboratory evaluation of an automated antimicrobial susceptibility system.

Authors:  K G Stubbs; K Wicher
Journal:  Am J Clin Pathol       Date:  1977-12       Impact factor: 2.493

5.  Incidence of "oxidase-variable" strains of Aeromonas hydrophila.

Authors:  T L Overman; R F D'Amato; K M Tomfohrde
Journal:  J Clin Microbiol       Date:  1979-02       Impact factor: 5.948

  5 in total
  10 in total

1.  In vitro susceptibilities of tropical strains of Aeromonas species from Queensland, Australia, to 22 antimicrobial agents.

Authors:  J M Koehler; L R Ashdown
Journal:  Antimicrob Agents Chemother       Date:  1993-04       Impact factor: 5.191

2.  Minimal inhibitory concentrations of antimicrobial agents against Aeromonas hydrophila determined with the Autobac MTS.

Authors:  T L Overman; J P Seabolt
Journal:  J Clin Microbiol       Date:  1983-06       Impact factor: 5.948

3.  In vitro susceptibilities of Aeromonas hydrophila to 32 antimicrobial agents.

Authors:  R J Fass; J Barnishan
Journal:  Antimicrob Agents Chemother       Date:  1981-02       Impact factor: 5.191

4.  In vitro susceptibilities of Aeromonas hydrophila against new antibiotics.

Authors:  V Fainstein; S Weaver; G P Bodey
Journal:  Antimicrob Agents Chemother       Date:  1982-09       Impact factor: 5.191

5.  Antimicrobial susceptibility patterns of Aeromonas jandaei, A. schubertii, A. trota, and A. veronii biotype veronii.

Authors:  T L Overman; J M Janda
Journal:  J Clin Microbiol       Date:  1999-03       Impact factor: 5.948

6.  Seasonal incidence of and antibiotic resistance among Aeromonas species isolated from domestic wastewater before and after treatment in stabilization ponds.

Authors:  L Hassani; B Imziln; A Boussaid; M J Gauthier
Journal:  Microb Ecol       Date:  1992-05       Impact factor: 4.552

7.  Antimicrobial susceptibility of sixty human fecal isolates of Aeromonas species.

Authors:  E J Kuijper; M F Peeters; B S Schoenmakers; H C Zanen
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1989-03       Impact factor: 3.267

8.  In vitro susceptibilities of Aeromonas hydrophila, Aeromonas sobria, and Aeromonas caviae to 22 antimicrobial agents.

Authors:  M R Motyl; G McKinley; J M Janda
Journal:  Antimicrob Agents Chemother       Date:  1985-07       Impact factor: 5.191

Review 9.  Co-trimoxazole (trimethoprim-sulfamethoxazole): an updated review of its antibacterial activity and clinical efficacy.

Authors:  G P Wormser; G T Keusch; R C Heel
Journal:  Drugs       Date:  1982-12       Impact factor: 9.546

10.  Predicting in vivo absorption of chloramphenicol in frogs using in vitro percutaneous absorption data.

Authors:  Victoria K Llewelyn; Lee Berger; Beverley D Glass
Journal:  BMC Vet Res       Date:  2021-01-28       Impact factor: 2.741

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.